BriaCell Therapeutics Corp.
BCTX
$2.02
-$0.05-2.42%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.13M | -6.29M | -5.80M | -1.21M | 1.72M |
| Total Depreciation and Amortization | 26.70K | 26.70K | 26.70K | 72.40K | 3.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 13.70K | -525.60K | 928.00K | -4.19M | -10.54M |
| Change in Net Operating Assets | -1.08M | 870.10K | -2.11M | 1.29M | 3.74M |
| Cash from Operations | -7.16M | -5.92M | -6.96M | -4.04M | -5.08M |
| Capital Expenditure | -- | -- | -- | -456.80K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -105.00K | -75.00K | -75.00K | 0.00 | -225.00K |
| Cash from Investing | -105.00K | -75.00K | -75.00K | -456.80K | -225.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 14.71M | 5.22M | 11.96M | 4.42M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 14.71M | 5.22M | 11.96M | 4.42M | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.45M | -778.60K | 4.93M | -73.60K | -5.31M |